HYBT
Heyu Biological Technology Corporation [HYBT] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HYBT Stock Summary
In the News
HYBT Financial details
Company Rating
-
Market Cap
361.36M
Income
-606.33K
Revenue
117.81K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-779.89
Forward P/E
-
PEG
-7.09
P/S
5440.84
P/B
-179.57
P/C
-
P/FCF
-445.17
Quick Ratio
0.01
Current Ratio
0.01
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
50%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
714.4%
EPS Q/Q
-84.21%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-207%
ROE
26%
ROC
0.22%
Gross Margin
70%
Oper. Margin
-698%
Profit Margin
-698%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.002-3.4
52W High
-
52W Low
-
RSI
-
Rel Volume
1.7
Avg Volume
498
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-17.8885
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 498
- Market Capitalization 361.36M
- CEO Mr. Ban Siong Ang
- Headquarters Xiamen,CN
- IPO Date 1999-12-06
-
Website
https://heyubt.com 
Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. It is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.
